2 unknown, 1 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Terminated 1 |
Follow Active Treatment: new trials by email Literature Review of Active Treatment trials Research Report on Active Treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response Moxifloxacin, Placebo - Community-acquired Pneumonia | Phase 4 | Unknown | David Garcia Cinca | 424 | 2019-02-15 | 2019-12-05 |
| Efficacy and Safety of LAIS® Mites Sublingual Tablets LAIS® - Allergic Conditions | Phase 4 | Unknown | Ajou University School of Medicine | 45 | 2014-10-01 | 2015-06-23 |
| The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac Patients Tredaptive (1 g extended release niacin+ 20 mg laropiprant), Placebo, Tredaptive - Coronary Artery Disease, Dyslipidemia | Phase 4 | Terminated | Sheba Medical Center | 8 | 2010-07-01 | 2016-10-19 |
Community-Acquired Pneumonia (1) · Coronary Artery Disease (1) · Dyslipidemias (1)
Ajou University School of Medicine (1) · David Garcia Cinca (1) · Sheba Medical Center (1)
Israel (1) · South Korea (1) · Spain (1)
Michael Shechter, MD, MA (1) · Shlomi Matetzky, MD (1)